Scientists identify novel antibodies for fighting malaria
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...
Tag: Antibodies
Immunocompromised adults show weaker response to RSV vaccines
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients ...
Zinc deficiency linked to increased risk of lung infection
Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii bacteria -; a leading cause of ventilator-associated pneumonia, according to a ...
HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute ...
Anti-inflammatory cytokine linked to capillary obstruction and cognitive decline in diabetes
Researchers discover that capillary obstruction in diabetes, triggered by elevated interleukin-10 signaling, may contribute to cognitive deficits independent of blood ...
Werner syndrome gene plays key role in maintaining cellular organization and DNA stability
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, ...
New test developed to simplify the diagnosis of allergies
Researchers at the University of Bern and Bern University Hospital have developed a test to simplify the diagnosis of allergies. ...
Long-lived plasma cells fail to establish after COVID mRNA vaccination, limiting long-term antibody response
Researchers discover that COVID-19 mRNA vaccines do not generate long-lasting plasma cells in the bone marrow, shedding light on why ...
Discovery of antibodies that boost complement activation against K. pneumoniae
New study uncovers how antibody combinations synergistically boost complement activation to combat drug-resistant Klebsiella pneumoniae infections. Study: Agnostic B cell selection ...
Innovative CAR-T cells effectively target glioblastoma with reduced toxicity
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than ...
